Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MNPR

Monopar Therapeutics (MNPR)

Monopar Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNPR
DateTimeSourceHeadlineSymbolCompany
07/22/20247:01AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MNPRMonopar Therapeutics Inc
07/22/20247:00AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MNPRMonopar Therapeutics Inc
07/11/20244:30PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MNPRMonopar Therapeutics Inc
07/09/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
07/09/20247:00AMGlobeNewswire Inc.Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-ZrNASDAQ:MNPRMonopar Therapeutics Inc
06/25/20248:00AMGlobeNewswire Inc.Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24NASDAQ:MNPRMonopar Therapeutics Inc
06/17/20246:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
06/11/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
06/11/20247:30AMGlobeNewswire Inc.Monopar and NorthStar Amend & Extend CollaborationNASDAQ:MNPRMonopar Therapeutics Inc
06/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
06/10/20248:00AMGlobeNewswire Inc.Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual MeetingNASDAQ:MNPRMonopar Therapeutics Inc
06/05/20246:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
05/31/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
05/30/20246:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
05/24/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
05/24/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
05/24/20248:00AMGlobeNewswire Inc.Monopar Announces CFO SuccessionNASDAQ:MNPRMonopar Therapeutics Inc
05/09/20247:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNPRMonopar Therapeutics Inc
05/09/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
05/09/20247:00AMGlobeNewswire Inc.Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma PipelineNASDAQ:MNPRMonopar Therapeutics Inc
04/18/20248:00AMGlobeNewswire Inc.Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual MeetingNASDAQ:MNPRMonopar Therapeutics Inc
04/16/20248:00AMGlobeNewswire Inc.Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization FindingsNASDAQ:MNPRMonopar Therapeutics Inc
04/10/20248:00AMGlobeNewswire Inc.Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer PatientsNASDAQ:MNPRMonopar Therapeutics Inc
03/28/20247:00AMGlobeNewswire Inc.Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
03/07/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
03/05/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
03/05/20247:00AMGlobeNewswire Inc.Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma ProgramNASDAQ:MNPRMonopar Therapeutics Inc
02/28/20241:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
02/27/20247:00AMGlobeNewswire Inc.Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical TrialNASDAQ:MNPRMonopar Therapeutics Inc
02/27/20246:59AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MNPR

Your Recent History

Delayed Upgrade Clock